Taken together, NMN treatment decreased fission (P616-DRP1, AD mice) and reduced fragmentation (CaMK2a-mito/eYFP mice) suggesting a shift in dynamics from fission to fusion. The gene discussed is NTS; the disease is Alzheimer disease.